Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_assertion type Assertion NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_head.
- NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_assertion wasGeneratedBy ECO_0000203 NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_provenance.
- NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_assertion wasDerivedFrom befree-20140225 NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_provenance.
- NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_assertion SIO_000772 22431922 NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_provenance.
- NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_assertion evidence source_evidence_literature NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_provenance.
- NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_assertion description "[Interestingly, the reduced expression of CLCA2 was frequently observed in various kinds of cancers including prostate cancer, whereas its expression was not affected in precancerous prostatic intraepithelial neoplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418295.RACxKkNCY-LEIzEcGhaDCh794qwN8w3xe35Wkjw7-Ps3g130_provenance.